Development and validation of an explainable artificial intelligence-based decision-supporting tool for prostate biopsy.

Journal: BJU international
Published Date: Aug 4, 2020

Abstract

OBJECTIVES: To develop and validate a risk calculator for prostate cancer (PCa) and clinically significant PCa (csPCa) using explainable artificial intelligence (XAI).

Authors

  • Jungyo Suh
    Department of Urology, Hospital Medicine Center, Seoul National University Hospital, Seoul, South Korea.
  • Sangjun Yoo
    Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea .
  • Juhyun Park
    Department of Urology, Asan Medical Center, Seoul, South Korea.
  • Sung Yong Cho
    Department of Urology, College of Medicine, Seoul National University Hospital, Seoul National University, Gwanak-gu, Seoul, South Korea.
  • Min Chul Cho
    Department of Urology, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, South Korea.
  • Hwancheol Son
    Department of Urology, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, South Korea.
  • Hyeon Jeong
    Department of Urology, Seoul National University College of Medicine, Seoul, South Korea.

Keywords

External Resources

Popular Topics
Recent Journals